Evidence map›Paper›PMID 37182419›Full record

ArticleEnvironment international2023

Beyond the cancer slope factor: Broad application of Bayesian and probabilistic approaches for cancer dose-response assessment.

Suji Jang, Kan Shao, Weihsueh A Chiu

Abstract read
In one paragraph

Article in Environment international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suji JangDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, USA.
Kan ShaoDepartment of Environmental and Occupational Health, School of Public Health, Indiana University, Bloomington, IN, USA.
Weihsueh A ChiuDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, USA. Electronic address: wchiu@cvm.tamu.edu.

Funding

Single cell, multi-parametric high throughput platform to classify endocrine disruptor potential of mixturesP42ES027704 · NIEHS · TEXAS A&M UNIVERSITY · PI Weihsueh A Chiu · 2017 to 2026
$21.2M
Texas A&M Center for Environmental Health Research (TiCER)P30ES029067 · NIEHS · TEXAS A&M UNIVERSITY · PI Galen Newman · 2019 to 2026
$13.0M
Develop and Commercialize the Bayesian Dose-Response Modeling System and ServicesR42ES032642 · NIEHS · KS AND ASSOCIATES, LLC · PI SHAO, KAN · 2020 to 2021
$2.0M
Software and services to advance dose-response modeling in chemical risk assesmentR41TR002567 · NCATS · KS AND ASSOCIATES, LLC · PI SHAO, KAN · 2018 to 2019
$300k
NCATS NIH HHS R41 TR002567NIEHS NIH HHS P30 ES029067NIEHS NIH HHS P42 ES027704NIEHS NIH HHS R42 ES032642
6 · The paper itself

Abstract

Traditional cancer slope factors derived from linear low-dose extrapolation give little consideration to uncertainties in dose-response model choice, interspecies extrapolation, and human variability. As noted previously by the National Academies, probabilistic methods can address these limitations, but have only been demonstrated in a few case studies. Here, we applied probabilistic approaches for Bayesian Model Averaging (BMA), interspecies extrapolation, and human variability distributions to 255 animal cancer bioassay datasets previously used by governmental agencies. We then derived predictions for both population cancer incidence and individual cancer risk. For model uncertainty, we found that lower confidence limits from BMA and from U.S. Environmental Protection Agency (EPA)'s Benchmark Dose Software (BMDS) correlated highly, with 86% differing by <10-fold. Incorporating other uncertainties and human variability, the lower confidence limits of the probabilistic risk-specific dose (RSD) at 10

Indexed as

NeoplasmsAnimalsBayes TheoremDose-Response Relationship, DrugHumansIncidenceRisk AssessmentUncertaintyBayesian model averagingCancer risk assessmentHuman variabilityProbabilistic risk assessmentUncertainty analysis

Identifiers

PMID37182419
PMCPMC10918611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.